Philips lowers 2026 sales growth outlook amid tariff pressure
The Dutch healthtech firm lowered its 2026 sales outlook to a maximum of 4.5 percent today. Rising U.S. tariffs continue to pressure margins despite cost cuts.
Insights:
Today, February 10, 2026, Koninklijke Philips N.V. announced a reduction in its comparable sales growth forecast for 2026, lowering the expected range to 3%–4.5%. This revised outlook is below the company's prior expectation of approximately 4.5%. Alongside the sales adjustment, the firm provided quantified free cash flow guidance for 2026, projecting a range of €1.3–1.5 billion.
